PEDIATRICS Vol. 99 No. 2 February 1997, pp. 204-208 (doi:10.1542/peds.99.2.204)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Behnke, M.
Right arrow Articles by Woods, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behnke, M.
Right arrow Articles by Woods, N. S.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 99 No. 2 February 1997, pp. 204-208

How Fetal Cocaine Exposure Increases Neonatal Hospital Costs

Received Oct 20, 1995; accepted Apr 11, 1996.

Marylou Behnke*, Fonda Davis Eyler*, Michael ConlonDagger , Olga Quiros Casanova§, and Nanci Stewart Woodsparallel

From the Departments of * Pediatrics, and Dagger  Biostatistics, University of Florida, Gainesville, Florida; § Lawnwood Regional Medical Center, Vero Beach, Florida; and parallel  Department of Psychology, Austin Peay State University, Clarksville, Tennessee.

Objective.  Our goals were to document hospital costs associated with prenatal cocaine exposure in an understudied population---women using rural county public health units who had minimal access to drug rehabilitation and whose cocaine of choice was crack with little other illicit drug use---and to explore why increased costs occur in an effort to identify cost-reduction strategies.

Methods.  We identified a sample of cocaine-exposed infants who were computer-matched to a control group with no history or evidence of cocaine exposure. Matching was performed one-to-one on the variables of maternal race, age, parity, time of entry into prenatal care, and alcohol and nicotine use. There were 327 live births, for whom 311 were correctly classified as to their prenatal cocaine use and had billing and medical records available for review (156 exposed, 155 nonexposed).

Results.  Hospital charges were positively correlated with length of stay. Cocaine-exposed infants had an across-the-board increase in utilization of hospital resources as well as higher hospital charges and longer lengths of stay. Cocaine-exposed infants were significantly younger in gestational age and lower in birth weight. Significantly more cocaine-exposed infants were admitted to the neonatal intensive care unit, had more social and family problems delaying discharge, and received more septic work-ups. In addition, of those infants urine-screened for cocaine at delivery, 92% were screened secondary to a maternal history of prenatal use.

Conclusions.  Cost-reduction strategies should be aimed at measures that reduce length of stay by addressing problems identified prenatally as an outpatient before delivery and by influencing objective decision-making regarding the need for medical interventions with the infant after birth.

Key words: cocaine, cost analysis, prenatal exposure, hospital costs, outcome.